The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
Pharmacy Benefit Managers (PBMs) control 80% of the US drug market. Learn how their formulary decisions and high-deductible ...
Caremark, Optum and Express Scripts artificially drove up the list prices of drugs by creating a system that gave preference ...